Proceedings of the National Academy of Sciences · 2019 · 80 citations · 45 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructural BiologyAllosteric Drug DesignDrug-receptor InteractionsLigand BindingLigand-based DesignReceptor PharmacologyReceptor-ligand InteractionsAllosteric Ligand BindingAllosteric SitesMuscarinic Receptor SubtypesMuscarinic ReceptorsRational DesignReceptor Allosteric SitesReceptor Subtype SpecificityReceptor-ligand Structural Biology
The human M 5 muscarinic acetylcholine receptor (mAChR) has recently emerged as an exciting therapeutic target for treating a range of disorders, including drug addiction. However, a lack of structural information for this receptor subtype has limited further drug development and validation. Here we report a high-resolution crystal structure of the human M 5 mAChR bound to the clinically used inverse agonist, tiotropium. This structure allowed for a comparison across all 5 mAChR family members that revealed important differences in both orthosteric and allosteric sites that could inform the rational design of selective ligands. These structural studies, together with chimeric swaps between the extracellular regions of the M 2 and M 5 mAChRs, provided structural insight into kinetic selectivity, where ligands show differential residency times between related family members. Collectively, our study provides important insights into the nature of orthosteric and allosteric ligand interaction across the mAChR family that could be exploited for the design of selective drugs.
45
Wolfgang Kabsch · Acta Crystallographica Section D Biological Crystallography · 2010 · 16.9K citations · Full text
Improvements to the <scp>APBS</scp> biomolecular solvation software suite
Elizabeth Jurrus, Dave Engel, Keith T. Star et al. · Protein Science · 2017 · 2.5K citations · Full text
Structure and dynamics of the M3 muscarinic acetylcholine receptor
Andrew C. Kruse, Jianxin Hu, Albert C. Pan et al. · Nature · 2012 · 816 citations